Separately, B. Riley reaffirmed a buy rating and issued a $6.40 price target on shares of Digirad Corporation in a research note on Saturday, August 5th.
Digirad Corporation (NASDAQ:DRAD) remained flat at $$2.50 during trading hours on Friday. 33,800 shares of the company’s stock traded hands, compared to its average volume of 78,929. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.44 and a quick ratio of 1.07. Digirad Corporation has a 52-week low of $1.90 and a 52-week high of $5.68. The firm has a market capitalization of $50.13, a P/E ratio of 8.62 and a beta of 1.85.
Digirad Corporation (NASDAQ:DRAD) last released its quarterly earnings data on Friday, November 3rd. The medical equipment provider reported $0.07 EPS for the quarter, topping the Zacks’ consensus estimate of $0.03 by $0.04. The firm had revenue of $28.56 million during the quarter, compared to analysts’ expectations of $31.21 million. Digirad Corporation had a negative net margin of 9.93% and a positive return on equity of 9.82%. analysts anticipate that Digirad Corporation will post 0.09 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by BBNS and is the sole property of of BBNS. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://baseballnewssource.com/markets/digirad-corporation-drad-downgraded-to-d-at-thestreet/1757522.html.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 30th. Shareholders of record on Monday, November 20th will be paid a dividend of $0.055 per share. This represents a $0.22 annualized dividend and a yield of 8.80%. The ex-dividend date of this dividend is Friday, November 17th. Digirad Corporation’s payout ratio is -37.93%.
A number of hedge funds and other institutional investors have recently modified their holdings of DRAD. Goldman Sachs Group Inc. raised its stake in Digirad Corporation by 5.0% during the first quarter. Goldman Sachs Group Inc. now owns 34,463 shares of the medical equipment provider’s stock worth $183,000 after acquiring an additional 1,640 shares in the last quarter. Spark Investment Management LLC increased its stake in shares of Digirad Corporation by 104.7% in the second quarter. Spark Investment Management LLC now owns 82,300 shares of the medical equipment provider’s stock valued at $333,000 after buying an additional 42,100 shares during the period. ARS Investment Partners LLC increased its stake in shares of Digirad Corporation by 3.4% in the second quarter. ARS Investment Partners LLC now owns 667,026 shares of the medical equipment provider’s stock valued at $2,701,000 after buying an additional 22,233 shares during the period. Kennedy Capital Management Inc. increased its stake in shares of Digirad Corporation by 37.5% in the second quarter. Kennedy Capital Management Inc. now owns 227,935 shares of the medical equipment provider’s stock valued at $923,000 after buying an additional 62,120 shares during the period. Finally, New York State Common Retirement Fund acquired a new position in shares of Digirad Corporation in the second quarter valued at approximately $574,000. 53.04% of the stock is owned by hedge funds and other institutional investors.
Digirad Corporation Company Profile
Digirad Corporation provides healthcare solutions. The Company’s segments include Diagnostic Services, Mobile Healthcare, Diagnostic Imaging and Medical Device Sales and Services. Through Diagnostic Services, the Company offers an imaging services program as an alternative to purchasing equipment or outsourcing the procedures to another physician or imaging center.
Receive News & Ratings for Digirad Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad Corporation and related companies with our FREE daily email newsletter.